Otitis Media With Effusion and Type 2 Inflammation Diseases

NCT06403319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100622

Last updated 2024-05-07

No results posted yet for this study

Summary

Otitis media with effusion (OME) is thought to be associated with comorbidities such as allergic rhinitis, gastroesophageal reflux disease, asthma, and more. Many of these comorbidities can be caused by type 2 inflammation (T2I). This study aims to characterize the risk of undergoing OME surgery. This retrospective, matched-cohort study involved the retrospective recruitment of patients from 2009 to 2020, using the Taiwan National Health Insurance Research Database (NHIRD)

Conditions

  • Otitis Media With Effusion

Sponsors & Collaborators

  • Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-01-01
Primary Completion
2020-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06403319 on ClinicalTrials.gov